YRBAF yields 4434.59% · MRK yields 2.76%● Live data
📍 YRBAF pulled ahead of the other in Year 1
Combined, YRBAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YRBAF + MRK for your $10,000?
Yorbeau Resources Inc. engages in the acquisition, exploration, and development of mineral properties in Canada. It explores for gold, silver, copper, zinc, and other base metals. The company holds 100% interests in the Rouyn property that consists of 1 mining concession and 94 claims having a total area of 2,684.88 hectares (ha) located in the south of Rouyn-Noranda, Québec; the Scott Lake property comprises three non-contiguous claim blocks consisting of 123 complete or partial claim cells covering an area of approximately 6,089 ha located in the townships of Lévy, Scott, and Obalski in northwestern Québec; and the Estrades-Caribou property, which consists of three contiguous claim blocks totaling 118 claims located in the Estrées Township in Québec. It also owns 100% interests in the Beschefer property that comprises 128 claims located in the Beschefer Township of northwestern Quebec; the Selbaie West property consists of 105 claims located in the Carheil and Brouillan townships in Québec; the Landrienne property, which consists of 59 claims located in the Landrienne Township in Québec; the Lemoine property comprising 102 claims located in the Lemoine, Rinfret, and Dollier townships in Québec; and the Castagnier property. In addition, the company holds interests in the Joutel-Explo Zinc project consisting of 118 claims and 1 mining concession; the Gemini-Turgeon projects comprises 189 claims; and the Allard property, which includes 43 claims located in the Abitibi region of Québec. Yorbeau Resources Inc. was incorporated in 1984 and is headquartered in Montreal, Canada.
Full YRBAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.